Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.

MLA

Dittrich, Tolga D., et al. “Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.” Neurocritical Care, vol. 41, no. 2, Oct. 2024, pp. 632–50. EBSCOhost, https://doi.org/10.1007/s12028-024-01971-x.

APA

Dittrich, T. D., Vock, D., Fisch, U., Hert, L., Baumann, S. M., Kliem, P. S. C., Rüegg, S., Marsch, S., De Marchis, G. M., & Sutter, R. (2024). Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review. Neurocritical Care, 41(2), 632–650. https://doi.org/10.1007/s12028-024-01971-x

Chicago

Dittrich, Tolga D, Dominik Vock, Urs Fisch, Lisa Hert, Sira M Baumann, Paulina S C Kliem, Stephan Rüegg, Stephan Marsch, Gian Marco De Marchis, and Raoul Sutter. 2024. “Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.” Neurocritical Care 41 (2): 632–50. doi:10.1007/s12028-024-01971-x.